'Alliance for LS polls depends on how Cong treats us'

Mangaluru, Jan 2: The Muslim Central Committee of Dakshina Kannada and Udupi has dropped its plan to stage a massive protest against the contentious Citizenship (Amendment) Act and National Register of Citizens on January 4 at Mangaluru’s Nehru Maidan.

Addressing a press conference here today, committee chief K S Mohammed Masood made this announcement.

“All the 28 organisations that had decided to stage protest under the leadership of the Muslim Central Committee, have unanimously agreed to temporarily cancel the protest plan after the city police refused permission for the event,” he said.

Mr Masood requested the people, especially the youth, not to lose patience. “No one should head to Nehru Maidan on January 4 as Muslim leaders have unanimously decided to cancel the protest,” he urged.

S M Rasheed Haji, Y Abdulla Kunhi, Umar UH, Ibrahim Kodichal, B M Mumtaz Ali, Khasim H K, Mansoor Ahmed Azad and Asif Deals were present in the press meet.

The United States of America has bought almost the entire world's supply of remdesivir, one of just two drugs proven to treat COVID-19. 

“President Trump has struck an amazing deal to ensure Americans have access to the first authorised therapeutic for Covid-19,” said the US health and human services secretary, Alex Azar. 

“To the extent possible, we want to ensure that any American patient who needs remdesivir can get it. The Trump administration is doing everything in our power to learn more about life-saving therapeutics for Covid-19 and secure access to these options for the American people.”

The announcement implies that no other country in the world will be able to buy remdesivir for next three months at least.

The anti-viral drug patented by the US-based Gilead biotech firm is the only one approved by the European Medicines Agency (EMA) to treat patients with the novel coronavirus.

The Trump administration has already shown that it is prepared to outbid and outmanoeuvre all other countries to secure the medical supplies it needs for the US.

“They’ve got access to most of the drug supply [of remdesivir], so there’s nothing for Europe,” said Dr Andrew Hill, senior visiting research fellow at Liverpool University.

Remdesivir, the first drug approved by licensing authorities in the US to treat Covid-19, is made by Gilead and has been shown to help people recover faster from the disease. 

The first 140,000 doses, supplied to drug trials around the world, have been used up. The Trump administration has now bought more than 500,000 doses, which is all of Gilead’s production for July and 90% of August and September.

Mangaluru, Mar 24: A Covid-19 patient from Kasaragod, who recently came from abroad travelled to Mangaluru twice, revealed Karnataka department of health and family welfare.

The 54-year-old person is confirmed as Covid-19 positive case yesterday.

He landed at Mangalore International Airport on March 10 at 5.30pm by Air India Express flight.

From there, he had travelled in his own vehicle to Kasaragod. He had coffee near Kasaragod and reached home at 7.30pm.

On March 11, he had visited local fish market and returned home at 10pm.

He had consulted a local doctor at Kasaragod on March 18 and later visited to Kasturba Medical College, Attavar at 3pm, visited reception and consulted a doctor.

He had tea at KMC canteen and travelled in an auto to Medicity and brought medicines and returned to Kasaragod by KSRTC bus.

Again he travelled to Mangaluru on March 20 in a private vehicle and visited a doctor and returned back to Kasargod in a private vehicle.

The health department has requested all passengers who travelled in the above said flight/aircraft, and KSRTC bus can self-report by dialing 104 or other helpline numbers.